On Friday, Moderna (MRNA) stock rose by 4.94% breaking out the $32 resistance level. Clinching above $34 has helped Moderna CEO Stephane Bancel to join the list of billionaires.As the war against the novel coronavirus intensifies all over the world, a lot of people are eying on the pharmaceutical companies spearheading the development of vaccines. Moderna Inc (NASDAQ: MRNA) stock continues enjoying a huge backing from investors, as the company pushes its vaccine to human testing. As a result,...
Read More »Moderna (MRNA) Stock 3.6% Down in Premarket, CEO Says Coronavirus Vaccine to Be Affordable
Moderna (MRNA) stock has fallen since the last week’s announcement of a possible vaccine for COVID-19. Its CEO has indicated that the prices for the coronavirus vaccine will be affordable.Moderna Inc (NASDAQ: MRNA) stock remained low. It lost 1.5% yesterday and today in the premarket it is nearly 4% down. This comes as the CEO of the biotech startup has indicated that the company’s COVID-19 vaccine will be affordable. Sources report that Stephane Bancel said that the price will be within the...
Read More »Moderna (MRNA) Stock Climbs 23% as World Is Waiting for the Coronavirus Vaccine Results
With coronavirus outbreak spreading a lot of fears to the global investors, talks of a vaccine are bolstering the Moderna (MRNA) stock value. However, it is still an early call, as the vaccine takes over a year to go through the regulatory testing rounds.The stocks of biotechnology company Moderna Inc (NASDAQ: MRNA) rocketed approximately 23 % on Wednesday after the company announced that the progress in making another experimental vaccine for a virus tied to birth defects is going at faster...
Read More »